| Patients |
Total | 8 |
Sex, males/females | 3/5 |
Median age in years (range) | 57.5 (26 - 77) |
M-Classification M1a M1b M1c |
2 (25.0%) 1 (12.5%) 5 (62.5%) |
Elevated lactate dehydrogenase values | 4 (50%) |
BRAF V600E mutation | 1 (12.5%) |
Median number of prior therapies (range) | 1 (1 - 2) |
Kind of prior therapies DTIC Immunotherapy (Allovectin-7) Paclitaxel Treosulfan/gemcitabine |
7 1 1 1 |
Median number of applied cycles of bevacizumab/cisplatin/carboplatin (range) | 5 (3 - 17) |